Physician

David Amaro-Driedger, MD

According to 2025 Medicare claims, David Amaro-Driedger, MD (NPI: 1447755251) practices interventional pain management (ipm) in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is MARK MALONE MD PA (NPI: 1407057250; TIN: 331043094) and primary practice location at 78749-1113.

Amaro-Driedger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 384 traditional Medicare patients, billed 2,922 HCPCS/CPT codes, and received $224,925 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 4,778 prescription claims across 1,153 beneficiaries totaling $201,358 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 53 records totaling $2,624. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$112K$225K2023 Medicare payment: $92,821 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $224,925 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232111,368$92,821
20243842,922$224,925

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$101K$201K2022 Drug cost: $15,110 (USD; Tot_Drug_Cst)2023 Drug cost: $62,819 (USD; Tot_Drug_Cst)2024 Drug cost: $201,358 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202287167$15,110
20233581,075$62,819
20241,1534,778$201,358

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0482Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms161247$192
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more147211$80
80307Testing for presence of drug, by chemistry analyzers236362$60
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's109125$13
96127Assessment of emotional or behavioral problems132145$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,52672,916$85,263
Xtampza ErOxycodone Myristate28840$17,898
OxycontinOxycodone Hcl371,094$14,995
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen52114,011$13,719
Hysingla ErHydrocodone Bitartrate25747$13,522

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.53$2,624Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Amaro-Driedger, MD?

Tedicare shows public-source Medicare data for David Amaro-Driedger, MD (NPI 1447755251), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Amaro-Driedger, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Amaro-Driedger, MD?

David Amaro-Driedger, MD is linked to MARK MALONE MD PA (billing NPI 1407057250) in the available physician profile data.

Does David Amaro-Driedger, MD have Open Payments data?

David Amaro-Driedger, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.